StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.12−0.25 (-10.57%)

Close on Nov 13, 2026Market cap $171.87MP/E –Yield –

Eledon Pharmaceuticals statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 18, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$171.87M
$272.32M
Enterprise Value
$102.17M
$146.23M
PB Ratio
5.58
2.00
P/TBV Ratio
5.58
2.22

Share statisticsIndustry

Shares Change (YoY)
47.4%
10.8%
Shares Change (QoQ)
0.68%
0.50%
Float
81M
49M
Shares Held by Insiders
0.68%
11.7%
Shares Held by Institutions
57.8%
56.4%

Short sellingIndustry

Short Interest
8M
–
Short Interest Change
4.51%
-0.80%
Short % of Float
10.2%
9.01%
Short % of Shares Outstanding
10.2%
6.30%
Days to Cover
7.51
5.15

Stock price statisticsIndustry

52-Week High
$4.49
–
52-Week Low
$1.35
–
20-Day Moving Average
$2.51
–
50-Day Moving Average
$2.56
–
200-Day Moving Average
$3.13
–
Average True Range (14)
$0.24
–
Price Change (1 Week)
-18.8%
-1.15%
Price Change (1 Month)
-6.83%
-4.87%
Price Change (3 Months)
-40.9%
-21.0%
Price Change (6 Months)
-44.3%
-20.6%
Price Change (YTD)
40.1%
-23.6%
Price Change (1 Year)
11.9%
-22.4%
Price Change (3 Years)
69.2%
-29.5%
Price Change (5 Years)
-62.4%
-77.9%
Price Change (10 Years)
-98.7%
-65.4%
Average Volume (10 Days)
748,022
–
Average Volume (20 Days)
944,405
–
Average Volume (90 Days)
928,790
–
Relative Volume
1.64
0.70
Relative Strength Index (14)
38.6
43.4
Volatility (1 Year)
69.5%
80.1%
Beta (5 Years)
0.87
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-257.1%
-49.9%
Return on Assets (ROA)
-71.9%
-40.6%

Financial positionIndustry

Current Ratio
6.30
3.30
Quick Ratio
5.96
2.39

EfficiencyIndustry

Profits Per Employee
-$2.58M
-$689.41K
Employee Count
33
74
WACC
9.46%
10.2%

Income statement (TTM)Industry

Net Income
-$85.04M
-$22.35M
EPS (Diluted)
-$0.73
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$69.70M
$17.76M
Net Cash Per Share
$0.86
$0.80
Equity (Book Value)
$30.80M
$53.89M
Book Value Per Share
$0.38
$1.50
Tangible Book Value
$30.80M
$27.13M
Working Capital
$62.01M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$78.36M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-49.5%
-21.8%

Scores and fair valueIndustry

Altman Z-Score
-2.75
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodELDNS&P 500DifferenceELDN per yearS&P 500 per year
1 month-9.6%-3.0%−6.6 pts
3 months-42.8%-2.8%−40.1 pts
Year to date+40.1%+11.5%+28.6 pts
1 year+20.2%+13.5%+6.7 pts
3 years+76.3%+77.7%−1.4 pts+20.8%+21.1%
5 years-62.4%+72.6%−135.0 pts-17.8%+11.5%
10 years-98.8%+308.2%−406.9 pts-35.6%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M ELDN shares were sold short on Oct 30, 2026, up 4.5% from the previous report, or 10.23% of the shares available to trade. At recent volumes it would take 7.5 days to buy them back. Over the last 20 sessions, 65.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20268,253,430+4.5%1,099,5937.5
Oct 15, 20267,896,950+0.6%770,15910.3
Sep 30, 20267,847,702-5.0%888,9378.8
Sep 15, 20268,259,268+6.6%919,1039.0
Aug 31, 20267,746,695+23.2%958,3818.1
Aug 14, 20266,289,078+1.2%915,0836.9
Jul 31, 20266,213,318+12.5%957,4006.5
Jul 15, 20265,522,678-29.5%1,426,0483.9
Jun 30, 20267,832,853+4.4%2,432,1703.2
Jun 15, 20267,501,607+3.0%1,005,4777.5
May 29, 20267,283,375+7.4%920,2167.9
May 15, 20266,781,022-10.2%1,265,7455.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?